cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes
- PMID: 23644383
- PMCID: PMC3671250
- DOI: 10.1038/emboj.2013.102
cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes
Abstract
Actin cytoskeletal damage induces inactivation of the oncoprotein YAP (Yes-associated protein). It is known that the serine/threonine kinase LATS (large tumour suppressor) inactivates YAP by phosphorylating its Ser127 and Ser381 residues. However, the events downstream of actin cytoskeletal changes that are involved in the regulation of the LATS-YAP pathway and the mechanism by which LATS differentially phosphorylates YAP on Ser127 and Ser381 in vivo have remained elusive. Here, we show that cyclic AMP (cAMP)-dependent protein kinase (PKA) phosphorylates LATS and thereby enhances its activity sufficiently to phosphorylate YAP on Ser381. We also found that PKA activity is involved in all contexts previously reported to trigger the LATS-YAP pathway, including actin cytoskeletal damage, G-protein-coupled receptor activation, and engagement of the Hippo pathway. Inhibition of PKA and overexpression of YAP cooperate to transform normal cells and amplify neural progenitor pools in developing chick embryos. We also implicate neurofibromin 2 as an AKAP (A-kinase-anchoring protein) scaffold protein that facilitates the function of the cAMP/PKA-LATS-YAP pathway. Our study thus incorporates PKA as novel component of the Hippo pathway.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures







Similar articles
-
Tumor suppressor LATS1 is a negative regulator of oncogene YAP.J Biol Chem. 2008 Feb 29;283(9):5496-509. doi: 10.1074/jbc.M709037200. Epub 2007 Dec 24. J Biol Chem. 2008. PMID: 18158288
-
The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes.Cell Death Dis. 2014 Nov 13;5(11):e1519. doi: 10.1038/cddis.2014.476. Cell Death Dis. 2014. PMID: 25393475 Free PMC article.
-
The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.J Biol Chem. 2017 Dec 22;292(51):21137-21148. doi: 10.1074/jbc.M117.819029. Epub 2017 Oct 5. J Biol Chem. 2017. PMID: 28982981 Free PMC article.
-
The NDR/LATS protein kinases in immunology and cancer biology.Semin Cancer Biol. 2018 Feb;48:104-114. doi: 10.1016/j.semcancer.2017.04.010. Epub 2017 Jun 1. Semin Cancer Biol. 2018. PMID: 28579171 Review.
-
Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling.Biofactors. 2009 Jul-Aug;35(4):338-45. doi: 10.1002/biof.47. Biofactors. 2009. PMID: 19484742 Review.
Cited by
-
LATS1/2 suppress NFκB and aberrant EMT initiation to permit pancreatic progenitor differentiation.PLoS Biol. 2019 Jul 19;17(7):e3000382. doi: 10.1371/journal.pbio.3000382. eCollection 2019 Jul. PLoS Biol. 2019. PMID: 31323030 Free PMC article.
-
Regulation of the Hippo pathway and implications for anticancer drug development.Trends Pharmacol Sci. 2013 Oct;34(10):581-9. doi: 10.1016/j.tips.2013.08.006. Epub 2013 Sep 16. Trends Pharmacol Sci. 2013. PMID: 24051213 Free PMC article. Review.
-
Vasodilator-stimulated phosphoprotein promotes liver metastasis of gastrointestinal cancer by activating a β1-integrin-FAK-YAP1/TAZ signaling pathway.NPJ Precis Oncol. 2018 Jan 23;2(1):2. doi: 10.1038/s41698-017-0045-7. eCollection 2018. NPJ Precis Oncol. 2018. PMID: 29872721 Free PMC article.
-
Hippo-YAP/TAZ signalling coordinates adipose plasticity and energy balance by uncoupling leptin expression from fat mass.Nat Metab. 2024 May;6(5):847-860. doi: 10.1038/s42255-024-01045-4. Epub 2024 May 29. Nat Metab. 2024. PMID: 38811804 Free PMC article.
-
The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis.Genes Dis. 2019 Dec 5;8(1):48-60. doi: 10.1016/j.gendis.2019.11.003. eCollection 2021 Jan. Genes Dis. 2019. PMID: 33569513 Free PMC article. Review.
References
-
- Angus L, Moleirinho S, Herron L, Sinha A, Zhang X, Niestrata M, Dholakia K, Prystowsky MB, Harvey KF, Reynolds PA, Gunn-Moore FJ (2012) Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP. Oncogene 31: 238–250 - PubMed
-
- Baldwin C, Garnis C, Zhang LW, Rosin MP, Lam WL (2005) Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65: 7561–7567 - PubMed
-
- Baumgartner R, Poernbacher I, Buser N, Hafen E, Stocker H (2010) The WW domain protein kibra acts upstream of Hippo in Drosophila. Developmental Cell 18: 309–316 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials